Selective TRAIL-Induced Apoptosis in Dysplastic Neoplasia of the Colon May Lead to New Neoadjuvant or Adjuvant Therapies

This publication has 36 references indexed in Scilit:

• TRAIL Induces Apoptosis in Human Colorectal Adenoma Cell Lines and Human Colorectal Adenomas
  Clinical Cancer Research, 2006
• The Proteasome Is Required for Rapid Initiation of Death Receptor-Induced Apoptosis
  Molecular and Cellular Biology, 2006
• Targeted Induction of Apoptosis in Cancer Management: The Emerging Role of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Receptor Activating Agents
  Journal of Clinical Oncology, 2005
• Resistance to TRAIL is associated with defects in ceramide signaling that can be overcome by exogenous C6-ceramide without requiring down-regulation of cellular FLICE inhibitory protein
  Molecular Cancer Therapeutics, 2005
• HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivo
  British Journal of Cancer, 2005
• Direct Repression of FLIP Expression by c-myc Is a Major Determinant of TRAIL Sensitivity
  Molecular and Cellular Biology, 2004
• Targeting death and decoy receptors of the tumour-necrosis factor superfamily
  Nature Reviews Cancer, 2002
• Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death
  Science, 2001
• Safety and antitumor activity of recombinant soluble Apo2 ligand
  Journal of Clinical Investigation, 1999
• Phase II Studies of Recombinant Human Tumor Necrosis Factor Alpha in Patients with Malignant Disease: A Summary of the Southwest Oncology Group Experience
  Journal of Immunotherapy, 1991